Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
 
Trade NameSIR-SPHERES
Classification Namemicrospheres radionuclide
ApplicantSIRTEX MEDICAL LIMITED
PMA NumberP990065
Date Received10/25/1999
Decision Date03/05/2002
Product Code
NAW[ Registered Establishments with NAW ]
Docket Number 03M-0010
Notice Date 01/23/2003
Advisory Committee Radiology
Expedited Review Granted? No
Combination Product No
Information About: Labeling, Approval Order, Summary of Safety and Effectiveness
Approval Order Statement 
Approval for sir-spheres. The device is indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (ihac) of fudr (floxuridine).
Approval Order Approval Order
Supplements: S001 S004 S006 
-
-